[#DIV28SUPER] Announcing the Stress, Trauma, and Resilience (STAR) T32 Research Fellowship Program

Dear Colleagues,

Please distribute widely. Apologies for any cross-postings.

A new NIH T32 postdoctoral research fellowship program in childhood Stress, Trauma, & Resilience (STAR) is available through the Warren Alpert Medical School of Brown University. This Research Fellowship Program (RFP) postdoctoral fellowship is located at the Miriam Hospital, in Providence, Rhode Island with start dates between now and January 2021.

The STAR T32 research training program is an intensive fellowship designed to prepare PhD and MD postdoctoral fellows to conduct cutting-edge, translational, developmentally informed research on childhood stress, trauma and resilience. The STAR T32 program takes a broad approach to stress, adversity, and trauma experienced by children and families and their impact on health outcomes across development, including research on adults with a history of early and later stress/trauma. Fellows emerge as innovative and productive independent investigators through intensive mentorship, foundational didactics, and formulation of an independent STAR research project and grant proposal. Candidates from under-represented backgrounds are especially encouraged to apply.

For further details regarding application, please visit the Postdoctoral Fellowship link at: https://www.brown.edu/clinical-psychology-training/postdoctoral-fellowship/postdoctoral-fellowship-applicants/application.

Applications received by July 15 will be given priority, however applications will continue to be reviewed on a rolling basis.

To learn more about the STAR Initiative, please visit https://www.brown.edu/initiatives/star/home

For questions, please email star-initiative@brown.edu.

--

Laura R. Stroud, Ph.D.
Professor | Department of Psychiatry and Human Behavior. Warren Alpert Medical School, Brown University

Senior Research Scientist | Centers for Behavioral and Preventive Medicine, The Miriam Hospital

Co-Director | Stress Trauma and Resilience (STAR) Initiative, Department of Psychiatry and Human Behavior, Brown University

Professor | Department of Behavioral and Social Sciences, School of Public Health, Brown University

Coro West, Suite 309

164 Summit Avenue

Providence, RI 02906

https://vivo.brown.edu/display/lstroud/

https://www.brown.edu/initiatives/star/

E-mail: Laura_Stroud@brown.edu

@LauraStroudPhD

@STAR_BrownDPHB

_____________________________ div28SUPER@lists.apa.org
Div28m members may post here list archive
twitter: @apadiv28 #div28

[#DIV28SUPER] APA 2020 Registration is Open!

Hi Everyone,

In case you missed it, the APA 2020 Virtual Convention registration is now open (https://convention.apa.org/)! As noted previously, the registration costs for convention are greatly reduced (~85%!). There's many exciting opportunities that will be available with the online setting including:

• Cross-cutting and collaborative sessions on topics ranging from sex and gender vulnerabilities in psychological health to mobile assessments to individual medicine to behavioral economics, and more!
• All material will be available from noon August 6^th, 2020 until August 1^st, 2021! That's right, one year of excellent content, on demand at your fingertips!
• Additional live content from Division 28, providing an opportunity to meet with friends and collaborators, old and new!

I hope that everyone will consider joining us for this exciting event! Feel free to reach out with any questions you might have.

Best,

Justin

Division 28 2020 Program Chair

---------------------------------------------------------

Justin C. Strickland, Ph.D.
Postdoctoral Fellow
Behavioral Pharmacology Research Unit
Department of Psychiatry and Behavioral Sciences
Johns Hopkins University School of Medicine
Phone: (410) 550-1975

[#DIV28SUPER] FW: Post doc search announcement for APA 28

Forwarded on behalf of Thomas Gould

 

From: Gould, Thomas J <tug70@psu.edu>
Sent: Sunday, July 5, 2020 10:47 AM
To: wlynch@virginia.edu
Subject: Post doc search announcement for APA 28

 

Hi Wendy,

I hope you are well.  I am searching for a postdoc.  Would it be possible to send out a version of this?

Cheers,

Tom

 

Postdoctoral Scholar

https://psu.wd1.myworkdayjobs.com/en-US/PSU_Academic/job/University-Park-Campus/NILA-Laboratory-Postdoctoral-Scholar_REQ_0000004063-1

 

JOB DESCRIPTION AND POSITION REQUIREMENTS:

The Neurobiology Investigation of Learning and Addiction Laboratory (NILA) is seeking a Postdoctoral Fellow to join Dr. Thomas Gould and his research team at The Pennsylvania State University. The NILA lab is located within the Penn State Department of Biobehavioral Health and conducts NIH-funded behavioral neuroscience research investigating the effects of nicotine on behavioral learning and its underlying neurobiological and genetic substrates. A current focus of the lab is the impact of developmental nicotine exposure-associated changes to the epigenome on brain and behavior. Our laboratory utilizes cutting-edge technologies and employs innovative integrative techniques in the study of learning, memory, and addiction. Postdoctoral Fellows are encouraged to develop independent research goals and will have continuous opportunity to publish and present their work. 

Candidate responsibilities will depend on candidate skills and interests as well as laboratory needs. Postdoctoral Fellow responsibilities generally include data collection and analysis, grant and manuscript preparation, and conference attendance and presentation. Qualified applicants will have earned a Ph.D. in Neuroscience, Pharmacology, Biology, Psychology, or a related field. Preference will be given to applicants with a strong background in mouse genetics, rodent behavior models, and neurobiological techniques and a proven track record of publications.

Candidate should submit a current CV and a list of three references.

 

 

 

 

Thomas J. Gould, Ph.D.
Jean Phillips Shibley Professor of Biobehavioral Health
Department Head
Department of Biobehavioral Health
219 Biobehavioral Health Bldg
The Pennsylvania State University
University Park, PA 16802
814-863-7256

 

Re: [#DIV28SUPER] Anti-Racism Statement and Diversity Plan

Let us not narrow our understanding of the racial unrest that is
presently being displayed around the world
As psychologists, we need to apply the professional skills that are
so important to our profession.
It would be unethical for us to apply knee jerk reactions in
understanding the dynamics of ,
the clients under our care. Understanding and comprehension takes time
to assimilate the dynamics of a
problem as it is presented to us. That which feels good to us is not
always in the best interests to the people involved.
T

On Thu, Jul 2, 2020 at 5:15 PM Lynch, Wendy J (wjl6w)
<wjl6w@virginia.edu> wrote:
>
> Dear Division 28 Members,
>
>
>
> I'm attaching an-Anti-Racism Statement on behalf of the Executive Committee of Division 28. Our statement also includes some actionable items that we are working to implement to help increase the representation of Black people at all levels of Division 28 membership. We also welcome your comments and suggestions on we can increase diversity within the Division.
>
>
>
> Thank you,
>
>
>
> Wendy J. Lynch, Ph.D.
>
> President, APA Division 28 (Psychopharmacology and Substance Abuse)
>
> Associate Professor of Psychiatry and Neurobehavioral Sciences
>
> Physical Address: 450 Ray C. Hunt Drive (Aurbach Building), Room G164
>
> Mailing Address: PO Box 801402, Charlottesville, VA 22904-1402
>
> 434-243-0580 (office)
>
> 434-249-3699 (cell)
>
>
>
>
>
> _____________________________ div28SUPER@lists.apa.org
> Div28m members may post here list archive
> twitter: @apadiv28 #div28



--
Dr. Reback

_____________________ div28SUPER@lists.apa.org _____________________
Div28m members #div28 subscribers corner: http://lists.apa.org

[#DIV28SUPER] NYTimes: Lester Grinspoon, Influential Marijuana Scholar, Dies at 92

Lester Grinspoon, Influential Marijuana Scholar, Dies at 92
https://www.nytimes.com/2020/07/02/science/lester-grinspoon-dead.html?referringSource=articleShare


Sent from my iPhone
_____________________ div28SUPER@lists.apa.org _____________________
Div28m members #div28 subscribers corner: http://lists.apa.org

[#DIV28SUPER] FW: ECP Special Issue

Forwarding on behalf of Andrew Huhn

 

 

From: Andrew Huhn <ahuhn1@jhu.edu>
Sent: Friday, July 3, 2020 12:41 PM
To: Lynch, Wendy J (wjl6w) <wjl6w@virginia.edu>
Subject: ECP Special Issue

 

 

Call for Papers: Experimental and Clinical Psychopharmacology

 

Special Issue on: Utilizing translational approaches to advance harm reduction strategies for substance use disorders

 

This special issue will provide an overview of current translational research from both human and non-human animal researchers investigating harm reduction strategies for substance use disorders (SUDs). The goal of this special issue is to highlight new and efficacious strategies to promote harm reduction in both clinical and preclinical models, and to catalyze future translational collaborations in the field. Particular topics of interest include but are not limited to nicotine-containing products such as heat-not-burn products and e-cigarettes, as well as products and strategies that reduce the incidence of opioid overdose including fentanyl test strips, safe injection sites, and safe delivery of heroin, hydromorphone, or other opioids. Another area of interest is research on other treatment outcomes associated with harm reduction across SUDs such as improved physical and/or mental health and social functioning. Regulatory-focused reports are also encouraged within this overall topic of research. We encourage submission of review articles and original research reports in these areas, including novel strategies or behavioral outcomes in clinical and preclinical models. Paired-research articles from different laboratories that are investigating similar behavioral outcomes in clinical and preclinical models are highly encouraged. If submitting paired articles, authors are also invited to submit a comment on that set of articles. Non-human animal research that is translatable to the human condition and human research that can be back-translated to a nonhuman model are encouraged. Papers addressing a variety of substances, including alcohol, marijuana, stimulants, and opiates, and their disorders, are welcome.

 

Researchers in this area may submit review articles or primary research reports to Experimental and Clinical Psychopharmacology to be considered for inclusion in this special issue. Manuscripts should be submitted as usual through the APA Online Submission Portal (http://pha.edmgr.com/), and the cover letter should indicate that the authors wish the manuscript to be considered for publication in the special issue: Utilizing translational approaches to advance harm reduction strategies for substance use disorders.  All submissions will undergo our normal peer review. Manuscripts received no later than October 1, 2020 will be considered for inclusion in the special issue. We strongly encourage individuals to contact the guest editors in advance with their ideas and a draft the title and abstract.

 

Questions or inquiries about the special issue can be directed to the Guest Editors of the issue, Cassandra Gipson, PhD, at cdgips2@uky.edu or Andrew Huhn, PhD, at ahuhn1@jhu.edu, or the Editor, William W. Stoops, PhD at William.stoops@uky.edu.

 

 

Andrew S. Huhn, Ph.D., M.B.A.

Assistant Professor

Behavioral Pharmacology Research Unit

Department of Psychiatry and Behavioral Sciences

Johns Hopkins University School of Medicine

5510 Nathan Shock Drive

Baltimore, MD 21224

Phone: (410) 550-1971

ahuhn1@jhu.edu

[#DIV28SUPER] Exaggerating Harmful Drug Effects

Hi All,

 

I'm attaching a timely in press Neuron article by Carl Hart. It's critical of drug researchers, but it also provides some practical tips that well-intentioned science leaders can take to dismantle systemic racism.

 

Thanks, Wendy

 

Wendy J. Lynch, Ph.D.

President, APA Division 28 (Psychopharmacology and Substance Abuse)

Associate Professor of Psychiatry and Neurobehavioral Sciences

Physical Address: 450 Ray C. Hunt Drive (Aurbach Building), Room G164

Mailing Address: PO Box 801402, Charlottesville, VA 22904-1402

434-243-0580 (office)

434-249-3699 (cell)